BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Idenix preclinical data

In vitro, IDX184 plus the company's IDX320 and IDX375 for 14 days resulted in RNA reductions of almost 4 log10, which the company said was substantially higher than the expected...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >